|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2001-6-26
|
|
pubmed:abstractText |
To assess the safety and efficacy of adjuvant combination therapy using 5-fluorouracil (5-FU) and low molecular weight heparin (LMWH) for prevention of proliferative vitreoretinopathy (PVR) after vitrectomy and retinal reattachment surgery.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0161-6420
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
108
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1179-83
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11425671-Adolescent,
pubmed-meshheading:11425671-Adult,
pubmed-meshheading:11425671-Aged,
pubmed-meshheading:11425671-Aged, 80 and over,
pubmed-meshheading:11425671-Double-Blind Method,
pubmed-meshheading:11425671-Drug Therapy, Combination,
pubmed-meshheading:11425671-Female,
pubmed-meshheading:11425671-Fluorouracil,
pubmed-meshheading:11425671-Follow-Up Studies,
pubmed-meshheading:11425671-Heparin, Low-Molecular-Weight,
pubmed-meshheading:11425671-Humans,
pubmed-meshheading:11425671-Male,
pubmed-meshheading:11425671-Middle Aged,
pubmed-meshheading:11425671-Prospective Studies,
pubmed-meshheading:11425671-Retinal Detachment,
pubmed-meshheading:11425671-Risk Factors,
pubmed-meshheading:11425671-Safety,
pubmed-meshheading:11425671-Visual Acuity,
pubmed-meshheading:11425671-Vitrectomy,
pubmed-meshheading:11425671-Vitreoretinopathy, Proliferative
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy : Results from a randomized, double-blind, controlled clinical trial.
|
|
pubmed:affiliation |
Departments of Vitreoretinal Surgery and Glaucoma, Moorfields Eye Hospital, London, England, UK.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
